โ… . Introduction

  • Leukosis๋ฅผ ์ผ์œผํ‚ค๋Š” ๋ฐ”์ด๋Ÿฌ์Šค์˜ ์ข…๋ฅ˜๋Š” ๋„ˆ๋ฌด ๋‹ค์–‘ํ•ด์„œ, L/S group (Leukosis/Sarcoma group)์ด๋ผ๊ณ  ํ•จ.
  • Lymphoid leukosis(LL) : avian leukosis virus(ALV)์— ์˜ํ•ด ๋ฐœ์ƒ. โ€œbig liver diseaseโ€ or โ€œvisceral lymphomatosisโ€๋ผ๊ณ  ๋ถˆ๋ฆผ.
  • ์œ ์ „์˜ ์˜ํ–ฅ์„ ๋งŽ์ด ๋ฐ›์Œ(๊ฐ€์กฑ๋ ฅ ์กด์žฌ). ๋ฐฑ์‹ ๋ณด๋‹ค๋Š” ์ €ํ•ญ์„ฑ ํ’ˆ์ข…์„ ๋งŒ๋“œ๋Š” ๊ฒƒ์œผ๋กœ ๋Œ€์ฒ˜.
  • ์ข…์–‘ ๋ฐœ์ƒ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ์‚ฐ๋ž€์œจ ๊ฐ์†Œ, ์ฒด์ค‘ ๊ฐ์†Œ, ๋ฉด์—ญ๋ ฅ ์ €ํ•˜(immunosuppression).
  • LL์€ ๋ชจ๋“  ๋‹ญ์ด ๊ฑธ๋ฆผ. / ์ƒˆ๋กœ ๋ฐœ๊ฒฌ๋œ subgroup J ALV๋Š” ์œก์šฉ ์ข…๊ณ„์˜ myelocyte๋งŒ target. LL์€ B cell, MDV๋Š” T cell target
  • LL์€ ์ „์„ธ๊ณ„์—์„œ ๋ฐœ๊ฒฌ๋จ. ์ˆ˜์ง/์ˆ˜ํ‰ ์ „ํŒŒ ๋ฐœ์ƒ. MDV๋Š” ์ˆ˜ํ‰ ์ „ํŒŒ๋งŒ ๊ฐ€๋Šฅ
  • ์ŠคํŠธ๋ ˆ์Šค์™€ ๋ฉด์—ญ ์–ต์ œ๋ฅผ ์ผ์œผํ‚ด โ†’ ALV์— ๋” ์ทจ์•ฝ, ๋‹ค๋ฅธ ์งˆ๋ณ‘์—๋„ ์ทจ์•ฝํ•ด์ง.
  • ๊ฐ์—ผ๋˜์–ด๋„ ํ•ญ์ฒด๊ฐ€ ์ƒ๊ธฐ์ง€ ์•Š๋Š” ๊ฒฝ์šฐ๊ฐ€ ํ”ํ•จ. & ํ•ญ์ฒด๊ฐ€ ์žˆ๋‹ค๊ณ  ๋ฐ˜๋“œ์‹œ LL์ด ๋ฐœํ˜„ํ•˜์ง€๋Š” ์•Š์Œ. (์ง„๋‹จ์˜ ์–ด๋ ค์›€)
  • ์‚ฌ๋žŒ์— ๊ฐ์—ผ๋˜์ง€๋Š” ์•Š์Œ.

โ…ก. History

1) Historical information

  • ๋งˆ๋ ‰๋ณ‘๊ณผ ์˜ค๋ž˜ ํ˜ผ๋™๋จ
  • 1868 : โ€œlymphosarcomatosisโ€
  • 1896 : โ€œfowl leukemiaโ€
  • 1921 : 3 pathological forms์˜ avian leukosis๋กœ ํ•™๊ณ„์— ๋ณด๊ณ ๋จ
    • lymphatic leukosis
    • myeloic leukosis
    • intravascular lymphoid leukosis
  • 1962 : ๋งˆ๋ ‰์ด ๋ฐœ๊ฒฌ๋˜๋ฉด์„œ LL์ด ๋ณธ๊ฒฉ์ ์œผ๋กœ ๊ตฌ๋ถ„๋จ

2) ๋ฐœ์ƒ๊ณผ ๋ถ„ํฌ

  • LL-associated mortality๋Š” 16์ฃผ๋ น ์ด์ƒ์—์„œ ํ”ํ•จ. MD๋ณด๋‹ค ๋Šฆ๊ฒŒ ๋ฐœํ˜„
  • ์œก๊ณ„์—์„œ๋Š” ํ•ด๋‹น์ด ์—†์Œ(16์ฃผ๋ น๊นŒ์ง€ ๊ฐ€์ง€ ์•Š์Œ). ์‚ฐ๋ž€์ข…๊ณ„์—์„œ ๋ฐœ์ƒ.
  • ์ „์„ธ๊ณ„์  ๋ถ„ํฌ
  • L/S virus๋Š” ๊ด‘๋ฒ”์œ„ํ•œ neoplastic condition์„ ์œ ๋ฐœ.
    • ๋ฐ”์ด๋Ÿฌ์Šค์— ๋”ฐ๋ผ ํƒ€๊ฒŸํ•˜๋Š” ์„ธํฌ๊ฐ€ ๋‹ค๋ฆ„. target cell์— ๋”ฐ๋ผ ๋‹ค์–‘ํ•œ ์œ„์น˜์—์„œ tumor ๋ฐœ์ƒ.
    • lymphoid leukosis๊ฐ€ ์••๋„์ ์œผ๋กœ ๋งŽ์ง€๋งŒ, osteopetrosis, hemangiomas, erythroblastosis, nephroblastomas, myeloblastosis, and myelocytomatosis ๋“ฑ ์•„์ฃผ ๋‹ค์–‘ํ•จ.
  • LL ์ €ํ•ญ์„ฑ ํ’ˆ์ข…์— ๋Œ€ํ•œ ์—ฐ๊ตฌ๊ฐ€ ํ™œ๋ฐœํ•จ.
    • ๋ฐ”์ด๋Ÿฌ์Šค ์ธ์ž์˜ ์ œ๊ฑฐํ•˜๊ฑฐ๋‚˜
    • ๋ฐ”์ด๋Ÿฌ์Šค์— ๊ฑธ๋ฆฌ์ง€ ์•Š๊ฒŒ๋” ํ’ˆ์ข…์„ ๊ฐœ๋Ÿ‰ํ•˜๊ฑฐ๋‚˜ (knock-in, knock-out)

โ…ข. Etiology

1) Classification

  • Family Retroviridae
    • Genus Alpharetrovirus
  • Retroviridae โ†’ ๋ฉด์—ญ๊ฒฐํ•์„ ์ผ์œผํ‚ด.
  • exogenous, endogenous ํ˜•ํƒœ๋กœ ์กด์žฌ.
Exogenous virus : ์™„์ „ํ•œ ํ˜•ํƒœ
  • non-defective (complete set of gene)
  • target cell์„ ๊ฐ์—ผ์‹œํ‚ด, complete & fully infectiousํ•œ ๋ฐ”์ด๋Ÿฌ์Šค ์ž…์ž๋ฅผ ์ƒ์‚ฐ.
  • ์ˆ˜ํ‰์ , ์ˆ˜์ง์  ์ „ํŒŒ ๊ฐ€๋Šฅ
  • provirus ํ˜•ํƒœ๋„ ์กด์žฌ ๊ฐ€๋Šฅ, ๋…๋ฆฝ์ ์ธ ์ž…์ž๋กœ ์กด์žฌ ๊ฐ€๋Šฅ.
    • provirus : ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ genome์— ์ผ๋ถ€์ฒ˜๋Ÿผ ๋ฐ•ํ˜€์žˆ์Œ. ๋ฐ•๋ฉธ์ด ๋ถˆ๊ฐ€.
    • ์ด provirus๋„ exogenous์ด๋ฏ€๋กœ complete viral capsid๋ฅผ ํ˜•์„ฑํ•จ
Endogenous virus : ์Šค์Šค๋กœ particle ๋งŒ๋“ค ์ˆ˜ ์—†์Œ
  • defective (incomplete set of gene)
  • ์Šค์Šค๋กœ particle์„ ๋งŒ๋“ค์ง€ ๋ชปํ•œ ์ƒํƒœ. ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ์™„์ „ํ•œ ํ˜•ํƒœ๋กœ ๋‚˜์˜ค์ง€ ๋ชปํ•˜๊ณ  ์ผ๋ถ€๋ถ„๋งŒ ์กด์žฌ.
  • ์ˆ™์ฃผ์„ธํฌ์˜ genome์— foreverํ•˜๊ฒŒ ํŒŒ๊ณ ๋“ค์–ด๊ฐ.
  • ๋ณต์ œํ•˜์ง€ ์•Š๊ฑฐ๋‚˜ ๋งค์šฐ ๋А๋ฆฐ ์†๋„๋กœ ๋ณต์ œ๋จ. non-oncogenicํ•˜์—ฌ tumor๋ฅผ ์ผ์œผํ‚ค์ง€ ๋ชปํ•จ.
  • ์‚ฌ์‹ค์ƒ ์ˆ˜์ง๊ฐ์—ผ๋งŒ ๊ฐ€๋Šฅํ•จ. โ‡’ endogenous, provirus ๋•Œ๋ฌธ์— ํ•ญ์›์ด ๊ฒ€์ถœ๋˜์—ˆ๋”๋ผ๋„ LL์ด๋ผ๊ณ  ํ•  ์ˆ˜ ์—†์Œ.

2) Properties

  • linear ssRNA virus
  • ์•ฝ 100nm์˜ ์ค‘์†Œํ˜• ๋ฐ”์ด๋Ÿฌ์Šค
  • oncogene ํ•จ์œ ํ•œ retrovirus์— ๊ฐ์—ผ โ†’ ๊ธ‰์†๋„๋กœ transfer์ด ์ผ์–ด๋‚จ.
  • Reverse transcriptase(RT) : viral RNA๋ฅผ viral DNA๋กœ โ†’ ๋”ฐ๋ผ์„œ ์ž์œ ๋กญ๊ฒŒ provirus๋ฅผ ํ™œ์„ฑํ™”์‹œํ‚ด.
  • ๊ตฌ์กฐ ๋‹จ๋ฐฑ์งˆ : exogenous๋Š” 3๊ฐœ ์ „๋ถ€, endogenous๋Š” ์ผ๋ถ€๋งŒ ๋ฐœํ˜„
    • Gag/pro gene
      • MA(p19) : envelope/capsid์˜ matrix protein
      • CA(p27) : capsid protein์„ ๊ตฌ์„ฑ, CA์˜ ์œ ๋ฌด๋กœ ๋ฐฑํ˜ˆ๋ณ‘์„ ์ง„๋‹จํ•จ.
      • NC : RNA processing & packaging
      • PR(protease) : cleavage of protein precursors
    • ==Pol gene== (polymerase gene)
      • p68 : RNA-/DNA-dependnet polymerase & RNase H
      • p32(IN, integrase) : viral DNA to host genome์˜ integration์— ์ค‘์š”
    • Env gene (envelope gene)
      • SU (surface protein, gp85๋ฅผ coding) : ๊ฐ๋ณ„ ์ง„๋‹จ์— ์ค‘์š”ํ•œ ๋ถ€๋ถ„, ๋งค์šฐ ์—ฐ์•ฝ(fragile)^[gene ๊ฐ€๊ณต ์‹œ SU gene์ด ์‰ฝ๊ฒŒ ํŒŒ๊ดด๋˜์–ด LL์˜ killed vaccine์„ ๋งŒ๋“ค๊ธฐ๊ฐ€ ์–ด๋ ต๋‹ค]
      • TM (transmembrane protein, gp37)
    • ๋ฐ”์ด๋Ÿฌ์Šค ๊ตฌ์กฐ ํ•ฉ์„ฑ์— ํ•„์š”ํ•œ ์„ธ ์œ ์ „์ž๋Š” genome์— ๋ผ์–ด์„œ provirus์˜ ํ˜•ํƒœ๋กœ ์กด์žฌ

3) Virus replication

  • ๋‹ค๋ฅธ ๋ฐ”์ด๋Ÿฌ์Šค์™€ ๋งค์šฐ ์œ ์‚ฌ.
  • attachment(์ˆ˜์šฉ์ฒด์—) - penetration(์„ธํฌ์งˆ์—) - denudation - transcription(vRNAโ†’vDNA) - integration(vDNAโ†’cDNA)

4) Strain

  • L/S group์˜ ๋ถ„๋ฅ˜๋Š” ์ˆ™์ฃผ ๋ฒ”์œ„, ๋ฐ”์ด๋Ÿฌ์Šค ์ค‘ํ™” ํŒจํ„ด, target cell infectivity์— ๋”ฐ๋ผ ๋‹ฌ๋ผ์ง.
  • ๋‹ญ์—์„œ 6์ข…๋ฅ˜์˜ subgroup ์กด์žฌ : A, B, C, D, E, J
    • A, B : ์ž์ฃผ ๋ฐœ์ƒ
    • C, D : ๊ฑฐ์˜ ๋ฐœ์ƒํ•˜์ง€ ์•Š์Œ
    • E : ์œ ์ผํ•˜๊ฒŒ endogenous
    • J : ์ตœ๊ทผ ๋ฐœ๊ฒฌ๋œ subgroup
    • >> A, B&J์˜ target cell
  • ๊ทธ ์™ธ์˜ ๊ฐ€๊ธˆ๋ฅ˜์—์„œ F, G, H, I ๋ฐœ๊ฒฌ๋จ.

5) Laboratory Host System

  • chick inoculation
  • chicken embryos : ์ €ํ•ญ์„ฑ ์žˆ๋Š” ๋‹ญ ํ’ˆ์ข…์— ์ ‘์ข…ํ•˜๋ฉด ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ์ž๋ผ์ง€ ์•Š์œผ๋ฏ€๋กœ, ํ’ˆ์ข… ์ฃผ์˜.
  • CAM : 11์ผ๋ น
  • Tumor pocks developed
  • Cell cultures : CEF(chicken embryo fibroblast) cells
    • C/O : ๋ชจ๋“  subgroup์˜ ALV
    • C/A, E : A, E๋ฅผ ์ œ์™ธํ•œ ๋ชจ๋“  ALV์—์„œ ์ž๋žŒ
    • C/A, B, D, E : subgroup C, J์—์„œ๋งŒ ์ž๋žŒ
    • C/E : E ์ œ์™ธ, exogenous ALV์—์„œ๋งŒ ์ž๋žŒ
    • C/E, J : E, J๋ฅผ ์ œ์™ธํ•œ ๋ชจ๋“  ALV์—์„œ ์ž๋žŒ
    • C/E + C/O : commercial SPF chick, ์—ฐ๊ตฌ์šฉ, vaccine&diagnostics ์ƒ์‚ฐ

6) Pathogenicity

1. Pluripotential nature of ALV
  • ์ข…์–‘์˜ type๊ณผ ๋ฐœ์ƒ๋ฅ ์— ์˜ํ–ฅ์„ ์ฃผ๋Š” ๋‹ค์–‘ํ•œ ์š”์ธ๋“ค์ด ์žˆ์Œ.
    • ๋ฐ”์ด๋Ÿฌ์Šค์˜ ์ข…๋ฅ˜, dose, ๊ฐ์—ผ ๊ฒฝ๋กœ, ๊ฐ์—ผ ๋‚˜์ด, transmission form, ์ˆ™์ฃผ์˜ ๋ฉด์—ญ ์ƒํƒœ, ๊ฐ์—ผ๋œ ๋‹ญ์˜ ํ’ˆ์ข…(genetic makeup), ๋‹ญ์˜ ์„ฑ๋ณ„
  • ALV infection์— ์˜ํ•ด ๋ฐœ์ƒํ•˜๋Š” ๋Œ€ํ‘œ์ ์ธ tumor
    • Lymphoid leukosis, Erythroblastosis๊ฐ€ 1, 2๋ฒˆ์งธ๋กœ ํ”ํ•จ. (๋ฆผํ”„๊ตฌ, ์ ํ˜ˆ๊ตฌ)
    • ๊ทธ ์™ธ myeloblastosis, myelocytomatosis, nephroblastoma, connective tissue tumor, epithelial tumor, osteropetrosis, endotheliomas(hemangioma: ํ˜ˆ๊ด€ ๋‚ดํ”ผ๊ฐ€ ํ„ฐ์ ธ ์ถœํ˜ˆ)
2. Virus-Host interaction
  • oncogene์ด ๋งŽ์ด ์กด์žฌํ•จ.
  • ๋‹ญ์˜ ํ’ˆ์ข…์—์„œ c-myc, c-erb๊ฐ€ ์žˆ์œผ๋ฉด ๋„ํƒœ. ์ด gene์ด ์žˆ์œผ๋ฉด ๋ฐฑํ˜ˆ๋ณ‘ ๊ธ‰์‚ฌ๋ฅผ ์˜๋ฏธํ•˜๊ธฐ ๋•Œ๋ฌธ์—, ํ’ˆ์ข… ๊ฐœ๋Ÿ‰ ์‹œ ์—†์• ๋ฒ„๋ฆผ.
    • ์ผ๋‹จ promoter-insertion ๊ธฐ์ „์— ์˜ํ•ด ํ™œ์„ฑํ™”๋˜๊ณ  ๋‚˜๋ฉด, neoplastic cell transformation ์œ ๋„๋จ.
  • ๋‹ญ์€ ๊ฒฝ์ œ๋™๋ฌผ์ด๋ผ ์ด๋Ÿฌํ•œ ์œ ์ „์ž๋ฅผ ์ œ๊ฑฐํ•˜๋ ค๊ณ  ๋…ธ๋ ฅํ•จ. (๋ฐ˜๋ ค๋™๋ฌผ, ์‚ฌ๋žŒ์—์„œ๋Š” ์œ ์ „์ž ๋ณ€ํ˜•๋ณด๋‹ค๋Š” ํ•ญ์•”์ œ ๋“ฑ)

โ…ฃ. Pathogenesis

1) Classical disease

  • LL(B-cell lymphoma of chickens) : B๋ฆผํ”„๊ตฌ๋ฅผ target. follicles of the bursa์— ์ข…์–‘ ์œ ๋ฐœ.
  • ์ผ๋ฐ˜์ ์ธ cancer๋ž‘ ๊ตฌ๋ณ„์ด ์ž˜ ์•ˆ๋จ (not specific)
  • ์‹ฌํ•ด์ง€๋ฉด bursa์™€ liver์˜ enlargement๋ฅผ ์ด‰์ง„์œผ๋กœ ์•Œ ์ˆ˜ ์žˆ๋‹ค.
  • bursa์˜ ๊ฑฐ๋Œ€ํ™”๋œ nodule๋„ ์ง„๋‹จ์— ๋„์›€.
  • subgroup J๋Š” myelocytic myeloid leukosis a& renal adenomas, ๊ทธ ์™ธ ๋งˆ์ด๋„ˆํ•œ ์ข…์–‘ ์œ ๋ฐœ (A~E์™€๋Š” ์กฐ๊ธˆ ๋‹ค๋ฆ„) (๊ฐ™์€ liver tumor์ง€๋งŒ, tumor๊ฐ€ ์ผ์–ด๋‚œ cell์˜ ์ข…๋ฅ˜์— ๋”ฐ๋ผ 3๊ฐ€์ง€๋กœ ๊ตฌ๋ถ„๋จ(lymphoid, erythrocyte, myelocyte) (์™ผ์ชฝ์ด liver. ๊ฐ„์—์„œ diffuse tumor๊ฐ€ ๋‚˜ํƒ€๋‚จ. ์˜ค๋ฅธ์ชฝ์€ spleen-focal tumor) (์ด๋ฐฐ์„ค๊ฐ•์˜ tumor์—์„œ๋Š” ๊ฑฐ๋Œ€ํ•œ nodule์ด ๊ด€์ฐฐ๋จ)

2) Target cells

  • subgroup A, B โ†’ B๋ฆผํ”„๊ตฌ
  • subgroup J โ†’ ๊ณจ์ˆ˜์˜ myelocyte

โ…ค. Epizootiology

  • Natural & Experimental Hosts
    • Chicken
      • Subgroup A, B, C, D : white leghorns > brown leghorns
      • Subgroup J : meat type breeders (์œก๊ณ„)
  • Transmission
    • Horizontal : ๋ถ„๋ณ€, ๊นƒํ„ธ์ด ์ฃผ ๋งค๊ฐœ์ฒด
    • Vertical transmission : 3๊ฐ€์ง€ ๋ฐฉ์‹
      • genetic : endogenous๊ฐ€ ์ˆ˜์ง์ ์œผ๋กœ ์ „๋‹ฌ (germline์— ๋“ค์–ด๊ฐ€๋Š” endogenous ALV์—์„œ ๋‚˜ํƒ€๋‚จ)
      • congenital : non-defective exogenous๊ฐ€ egg albumin์„ ํ†ตํ•ด ์ „๋‹ฌ
      • Horizontal transmission of exogenous ALVโ€™s : ๋ฐ€์ ‘ํ•œ ์ ‘์ด‰์— ์˜ํ•ด
  • ์ž ๋ณต๊ธฐ๋Š” 14-30์ฃผ

โ…ฅ. Diagnosis

  • History
  • ์ž„์ƒ ์ฆ์ƒ, ๋ณ‘๋ณ€
  • ๋ถ„๋ฆฌ์™€ ๋™์ •
  • Blood, serum์—์„œ ๋‹ค์–‘ํ•œ cell ๊ด€์ฐฐ.
Isolation
Antigen detection
  • ==RIF== : Resistance-inducing factor test
    • ํŠน์ • CEF์—์„œ ์ž๋ผ์ง€ ์•Š๋Š” ๊ฒƒ์„ ์ด์šฉํ•˜์—ฌ subgroupingํ•œ๋‹ค.
  • COFAL : Complement fixation(CF) for avain leukosis
  • NP : Nonproducer cell activation
  • PM : Phenotypic mixing test
  • ์œ„ 4๊ฐœ๊ฐ€ ALV detection์—์„œ ํŠนํžˆ ์ค‘์š”ํ•จ. (๊ทธ ์™ธ์—๋„ ALV p27์˜ ELISA, PCR, IP, โ€ฆ)

โ…ฆ. Prevention & Control

[๊ตญ์‹œ์— ๊ทธ๋Œ€๋กœ ๋‚˜์˜ค๋Š” ํ‘œ๋‹ˆ๊นŒ, ๊ทธ๋ƒฅ ์™ธ์šฐ๊ธฐโญโญ]

CriteriaMarekโ€™s diseaseLymphoid leukosis
Age์ˆ˜์ผ ~ ์ˆ˜์ฃผ
๋งˆ๋ ‰์ด ํ›จ์”ฌ ๋น ๋ฆ„
16์ฃผ ์ด์ƒ
Signs๋งˆ๋น„ ์ฆ์ƒ์ด ํŠน์ง•์ ๋งˆ๋น„ X
Incidence
(๋ฐœ์ƒ๋ฅ )
5% ์ด์ƒ์ผ๋ฐ˜์ ์œผ๋กœ 5% ์ •๋„
(subgroup J ์ œ์™ธ)
Gross lesions (๋ณ‘๋ณ€)
Neural enlargementFrequent
์‹ ๊ฒฝ ๋ฌธ์ œ๊ฐ€ ๋‘๋“œ๋Ÿฌ์ง€๋ฉด ๋ฌด์กฐ๊ฑด MDV
X
bursa of Fabriciusdiffuse enlargement / atrophy
F๋‚ญ์ด diffuseํ•˜๊ฒŒ ์ปค์ ธ ์žˆ์œผ๋ฉด ๋งˆ๋ ‰
nodular tumors
nodularํ•œ ์ข…์–‘์ด ๋ณด์ด๋ฉด LL
Proventriculus, skin, muscle
tumor
์„ ์œ„, ํ”ผ๋ถ€, ๊ทผ์œก ์ข…์–‘ OX
Microscopic lesions (์กฐ์งํ•™์  ๋ณ‘๋ณ€)
Neural involvement์‹ ๊ฒฝ์นจํ•ด OX
Liver tumorperivascularfocal, diffuse
Spleen tumordiffuse
๋น„์žฅ์ด ํฌ๊ฒŒ ํ™• ํผ์ ธ๋‚˜์˜ค๋Š” ๊ฒƒ ๊ฐ™์œผ๋ฉด ๋งˆ๋ ‰
focal
์ •์ƒ ์กฐ์ง์ด๋ž‘ ๋น„์Šทํ•˜๋ฉด LL
bursa of Fabriciousbursa sector๊ฐ€ ์•ˆ์ชฝ (interfollicular tumor)๋ฐ”๊นฅ์ชฝ (intrafollicular tumor)
Skin/feather follicleํ”ผ๋ถ€/๊นƒํ„ธ ๋ฆผํ”„์กฐ์ง์˜ ๊ณผํ˜•์„ฑ O
ํ”ผ๋ถ€ ์งˆํ™˜์ด ์žˆ๋Š” ์ชฝ์€ ๊ฑฐ์˜ ๋งˆ๋ ‰๋ณ‘
X
CNSCNS ๋ณ‘๋ณ€ ์กด์žฌX
Cytology of tumorpleomorphic lymphoid cell ๋งŽ์Œ,
์—ฌ๋Ÿฌ ํฌ๊ธฐ์˜ cell์ด ์„ž์—ฌ์žˆ์Œ
tumor ์‚ฌ์ด์ฆˆ๊ฐ€ ๋‹ค์–‘ํ•˜๋ฉด ๋งˆ๋ ‰
morphology๊ฐ€ uniform
๋‹จ์ผํ•˜๋ฉด LL
neoplastic lymphoid cellT-lymphocytes๋ฅผ target
(CD4+ T cell)
B-lymphocytes๋ฅผ target
MATSA-bearing cellsO
MATSA๋Š” ๋งˆ๋ ‰์—์„œ๋งŒ ๊ด€์ฐฐ๋จ
X
distributiongonad์„ ๊ฐ€์žฅ ๋งŽ์ด ๊ณต๊ฒฉํ•จ
+ liver, spleen
bursa๋ฅผ ๊ฐ€์žฅ ๋งŽ์ด ๊ณต๊ฒฉํ•จ
+ liver, spleen
  • LL์— ๋Œ€ํ•œ control, reduction, eradication์ด ์ž˜ ๋˜๊ณ  ์žˆ์Œ (๋Œ€๋ถ€๋ถ„ ์œก์ข… ๋‹จ๊ณ„์—์„œ control)
  • Subgroup J๋Š” ์ˆ˜ํ‰ ์ „ํŒŒ๋ฅผ ํ•˜๊ธฐ ๋•Œ๋ฌธ์— ์กฐ๊ธˆ ๊ณจ์น˜์•„ํ”ˆ ์ผ€์ด์Šค